SCOPOLAMINE

SCOPOLAMINE was reported 3672 times

These side effects are most commonly reported by patients taking SCOPOLAMINE:

# Side effect Count
0 NAUSEA 711
1 OFF LABEL USE 609
2 VOMITING 501
3 DIZZINESS 454
4 HEADACHE 366
5 DRUG INEFFECTIVE 346
6 FATIGUE 300
7 VISION BLURRED 279
8 DEATH 257
9 DIARRHOEA 252
10 MALAISE 252
11 CONFUSIONAL STATE 243
12 PAIN 241
13 DYSPNOEA 207
14 DRY MOUTH 205
15 MYDRIASIS 202
16 PRODUCT USE IN UNAPPROVED INDICATION 183
17 ANXIETY 182
18 PRODUCT QUALITY ISSUE 180
19 HALLUCINATION 174
20 ASTHENIA 171
21 FALL 171
22 PYREXIA 165
23 PNEUMONIA 164
24 RASH 154
25 FEELING ABNORMAL 151
26 WEIGHT DECREASED 149
27 SOMNOLENCE 141
28 ABDOMINAL PAIN 137
29 CONSTIPATION 132
30 DECREASED APPETITE 132
31 DEHYDRATION 132
32 HYPERSENSITIVITY 126
33 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 122
34 URINARY TRACT INFECTION 116
35 DISORIENTATION 115
36 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 115
37 HYPOTENSION 115
38 COUGH 114
39 PRODUCT ADHESION ISSUE 111
40 VERTIGO 110
41 ARTHRALGIA 104
42 DRUG INTERACTION 104
43 HYPERTENSION 104
44 CONDITION AGGRAVATED 102
45 PRURITUS 99
46 WITHDRAWAL SYNDROME 99
47 APPLICATION SITE ERYTHEMA 98
48 BACK PAIN 97
49 PAIN IN EXTREMITY 96
50 AGITATION 95
51 BALANCE DISORDER 95
52 INSOMNIA 95
53 ANAEMIA 94
54 TREMOR 94
55 OVERDOSE 91
56 GAIT DISTURBANCE 89
57 TACHYCARDIA 89
58 DYSPHAGIA 88
59 THERAPEUTIC RESPONSE UNEXPECTED 88
60 PRODUCT USE ISSUE 87
61 THROMBOCYTOPENIA 87
62 APPLICATION SITE PRURITUS 86
63 DRUG HYPERSENSITIVITY 85
64 CHEST PAIN 84
65 TOXICITY TO VARIOUS AGENTS 84
66 VISUAL IMPAIRMENT 84
67 SEIZURE 82
68 PARAESTHESIA 81
69 DRUG INTOLERANCE 80
70 DYSPHONIA 78
71 RENAL FAILURE 77
72 ABDOMINAL PAIN UPPER 76
73 DEPRESSION 74
74 APPLICATION SITE IRRITATION 73
75 SWELLING FACE 73
76 DRUG WITHDRAWAL SYNDROME 71
77 MEMORY IMPAIRMENT 71
78 PRODUCT DOSE OMISSION ISSUE 71
79 LOSS OF CONSCIOUSNESS 70
80 SEPSIS 70
81 HYPERHIDROSIS 69
82 ACUTE KIDNEY INJURY 68
83 NEUTROPENIA 68
84 APPLICATION SITE RASH 67
85 AMNESIA 66
86 PLATELET COUNT DECREASED 65
87 FEBRILE NEUTROPENIA 64
88 SPEECH DISORDER 64
89 INFECTION 63
90 DELIRIUM 61
91 RESPIRATORY FAILURE 61
92 WHITE BLOOD CELL COUNT DECREASED 61
93 HYPOAESTHESIA 60
94 MIGRAINE 60
95 ANGIOEDEMA 58
96 INCORRECT DRUG ADMINISTRATION DURATION 58
97 OEDEMA PERIPHERAL 58
98 ERYTHEMA 57
99 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 56
100 MUSCLE SPASMS 56
101 HAEMOGLOBIN DECREASED 55
102 SWOLLEN TONGUE 55
103 WEIGHT INCREASED 55
104 NASOPHARYNGITIS 54
105 PLEURAL EFFUSION 54
106 EMOTIONAL DISTRESS 53
107 HOSPITALISATION 53
108 MUSCULAR WEAKNESS 53
109 PALPITATIONS 53
110 ABDOMINAL DISTENSION 52
111 ADVERSE DRUG REACTION 52
112 APPLICATION SITE PAIN 52
113 CEREBROVASCULAR ACCIDENT 52
114 DISTURBANCE IN ATTENTION 52
115 INJURY 52
116 PNEUMONIA ASPIRATION 52
117 CARDIAC ARREST 51
118 CHEST DISCOMFORT 51
119 DRUG DEPENDENCE 51
120 OROPHARYNGEAL PAIN 51
121 PERIPHERAL SWELLING 50
122 GASTROOESOPHAGEAL REFLUX DISEASE 48
123 INFLUENZA 48
124 PULMONARY EMBOLISM 48
125 SEPTIC SHOCK 48
126 UPPER RESPIRATORY TRACT INFECTION 48
127 BRADYCARDIA 47
128 CHILLS 47
129 INCORRECT DOSE ADMINISTERED 47
130 MALIGNANT NEOPLASM PROGRESSION 47
131 SINUSITIS 47
132 BRONCHITIS 46
133 ILLNESS 46
134 INTESTINAL OBSTRUCTION 46
135 BLOOD PRESSURE INCREASED 45
136 COVID-19 45
137 DYSKINESIA 45
138 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 45
139 RESTLESSNESS 45
140 ABDOMINAL DISCOMFORT 44
141 INTENTIONAL PRODUCT MISUSE 44
142 ASTHMA 43
143 NEUROPATHY PERIPHERAL 43
144 STRESS 43
145 URINARY RETENTION 43
146 ANTICHOLINERGIC SYNDROME 42
147 BLOOD CREATININE INCREASED 42
148 HYPOXIA 42
149 SYNCOPE 42
150 GENERAL PHYSICAL HEALTH DETERIORATION 41
151 HYPOKALAEMIA 41
152 HYPONATRAEMIA 41
153 UNEVALUABLE EVENT 41
154 STOMATITIS 40
155 APPLICATION SITE REACTION 39
156 BLOOD PRESSURE DECREASED 39
157 DISEASE PROGRESSION 39
158 EYE PAIN 39
159 LETHARGY 39
160 MYALGIA 39
161 CHRONIC KIDNEY DISEASE 38
162 DYSURIA 38
163 MOTION SICKNESS 38
164 ABNORMAL BEHAVIOUR 37
165 ATRIAL FIBRILLATION 37
166 DRY SKIN 37
167 DYSPEPSIA 37
168 GASTROINTESTINAL DISORDER 37
169 SALIVARY HYPERSECRETION 37
170 URTICARIA 37
171 ALANINE AMINOTRANSFERASE INCREASED 36
172 COLITIS 36
173 DYSARTHRIA 36
174 FEAR 36
175 HALLUCINATION, VISUAL 36
176 HEART RATE INCREASED 36
177 SUICIDAL IDEATION 35
178 APHASIA 34
179 DIPLOPIA 34
180 MENTAL STATUS CHANGES 34
181 PANCYTOPENIA 34
182 RENAL IMPAIRMENT 34
183 UNRESPONSIVE TO STIMULI 34
184 ACUTE RESPIRATORY FAILURE 33
185 ASCITES 33
186 BLOOD GLUCOSE INCREASED 33
187 DEEP VEIN THROMBOSIS 33
188 FLUSHING 33
189 RETCHING 33
190 WRONG TECHNIQUE IN DRUG USAGE PROCESS 33
191 JOINT SWELLING 32
192 RASH ERYTHEMATOUS 32
193 ACCIDENTAL EXPOSURE TO PRODUCT 31
194 CHOLELITHIASIS 31
195 FLUID RETENTION 31
196 INTENTIONAL PRODUCT USE ISSUE 31
197 RENAL FAILURE ACUTE 31
198 WHEEZING 31
199 CELLULITIS 30
200 COGNITIVE DISORDER 30
201 DRY EYE 30
202 NEUTROPHIL COUNT DECREASED 30
203 ALOPECIA 29
204 APPLICATION SITE BURN 29
205 ASPIRATION 29
206 GASTROINTESTINAL HAEMORRHAGE 29
207 OXYGEN SATURATION DECREASED 29
208 BLISTER 28
209 COMA 28
210 HEAD INJURY 28
211 LYMPHOCYTE COUNT DECREASED 28
212 SURGERY 28
213 CARDIO-RESPIRATORY ARREST 27
214 CONVULSION 27
215 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 27
216 HAEMORRHAGE 27
217 HEPATIC ENZYME INCREASED 27
218 ILL-DEFINED DISORDER 27
219 PHOTOPHOBIA 27
220 PRODUCTIVE COUGH 27
221 PSYCHOTIC DISORDER 27
222 APPLICATION SITE VESICLES 26
223 ASPARTATE AMINOTRANSFERASE INCREASED 26
224 BLOOD POTASSIUM DECREASED 26
225 CARDIAC FAILURE 26
226 HOT FLUSH 26
227 INFUSION RELATED REACTION 26
228 PULMONARY OEDEMA 26
229 RENAL INJURY 26
230 SKIN IRRITATION 26
231 SWELLING 26
232 ABASIA 25
233 CONTUSION 25
234 CYTOKINE RELEASE SYNDROME 25
235 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25
236 DYSGEUSIA 25
237 DYSSTASIA 25
238 HEART RATE DECREASED 25
239 NEPHROLITHIASIS 25
240 RESPIRATORY DISTRESS 25
241 SEDATION 25
242 TINNITUS 25
243 BURNING SENSATION 24
244 ILEUS 24
245 IMPAIRED WORK ABILITY 24
246 LEUKOPENIA 24
247 MENTAL DISORDER 24
248 RHEUMATOID ARTHRITIS 24
249 SKIN EXFOLIATION 24
250 BLOOD UREA INCREASED 23
251 CONTRAINDICATED PRODUCT ADMINISTERED 23
252 DIABETES MELLITUS 23
253 DISCOMFORT 23
254 EXPOSURE DURING PREGNANCY 23
255 HIATUS HERNIA 23
256 HYPERGLYCAEMIA 23
257 INFLUENZA LIKE ILLNESS 23
258 INJECTION SITE PAIN 23
259 MEDICATION ERROR 23
260 OSTEOARTHRITIS 23
261 PANCREATITIS 23
262 ANHEDONIA 22
263 DEVICE RELATED INFECTION 22
264 MATERNAL EXPOSURE DURING PREGNANCY 22
265 NERVOUSNESS 22
266 OEDEMA 22
267 PRODUCT COMPLAINT 22
268 TREATMENT FAILURE 22
269 VIRAL INFECTION 22
270 ACTIVITIES OF DAILY LIVING IMPAIRED 21
271 AKATHISIA 21
272 BLOOD BILIRUBIN INCREASED 21
273 CHOKING 21
274 CYSTITIS 21
275 HYPOPHAGIA 21
276 LIMB DISCOMFORT 21
277 LUNG DISORDER 21
278 METASTASES TO CENTRAL NERVOUS SYSTEM 21
279 MOBILITY DECREASED 21
280 MULTIPLE SCLEROSIS RELAPSE 21
281 MYOCARDIAL INFARCTION 21
282 PANIC ATTACK 21
283 PLASMA CELL MYELOMA 21
284 PNEUMOTHORAX 21
285 WHITE BLOOD CELL COUNT INCREASED 21
286 ARRHYTHMIA 20
287 BLINDNESS 20
288 CRYING 20
289 DEMENTIA 20
290 DERMATITIS CONTACT 20
291 ECZEMA 20
292 HYPERSOMNIA 20
293 IMPAIRED DRIVING ABILITY 20
294 MENTAL IMPAIRMENT 20
295 MUSCULOSKELETAL STIFFNESS 20
296 NECK PAIN 20
297 PARANOIA 20
298 PSORIASIS 20
299 STEVENS-JOHNSON SYNDROME 20
300 SUPRAVENTRICULAR TACHYCARDIA 20
301 THROAT IRRITATION 20
302 URINARY INCONTINENCE 20
303 CARDIAC FAILURE CONGESTIVE 19
304 ELECTROCARDIOGRAM QT PROLONGED 19
305 HAEMATOCHEZIA 19
306 HYPERLIPIDAEMIA 19
307 NEOPLASM PROGRESSION 19
308 NEUTROPHIL COUNT INCREASED 19
309 PRE-EXISTING CONDITION IMPROVED 19
310 PRESCRIBED OVERDOSE 19
311 SCAR 19
312 SKIN DISCOLOURATION 19
313 THROMBOSIS 19
314 CARDIAC DISORDER 18
315 COORDINATION ABNORMAL 18
316 DEPRESSED LEVEL OF CONSCIOUSNESS 18
317 DISABILITY 18
318 ENCEPHALOPATHY 18
319 GAIT INABILITY 18
320 HALLUCINATION, AUDITORY 18
321 IMMUNODEFICIENCY 18
322 NERVOUS SYSTEM DISORDER 18
323 PERICARDIAL EFFUSION 18
324 SMALL INTESTINAL OBSTRUCTION 18
325 TRICUSPID VALVE INCOMPETENCE 18
326 ALTERED STATE OF CONSCIOUSNESS 17
327 BEDRIDDEN 17
328 DRUG ADMINISTRATION ERROR 17
329 DRY THROAT 17
330 FEEDING DISORDER 17
331 FLATULENCE 17
332 HYPERKALAEMIA 17
333 INTERVERTEBRAL DISC PROTRUSION 17
334 MULTI-ORGAN FAILURE 17
335 OCULAR HYPERAEMIA 17
336 PAIN IN JAW 17
337 PNEUMONITIS 17
338 RED BLOOD CELL COUNT DECREASED 17
339 RENAL DISORDER 17
340 SEASONAL ALLERGY 17
341 SLEEP DISORDER 17
342 TACHYPNOEA 17
343 ADVERSE EVENT 16
344 ARTHRITIS 16
345 ATELECTASIS 16
346 C-REACTIVE PROTEIN INCREASED 16
347 CROHN^S DISEASE 16
348 DELUSION 16
349 HAEMORRHOIDS 16
350 IMPAIRED GASTRIC EMPTYING 16
351 INFLAMMATION 16
352 IRRITABILITY 16
353 MOVEMENT DISORDER 16
354 MUCOSAL INFLAMMATION 16
355 MUSCLE SPASTICITY 16
356 NEOPLASM MALIGNANT 16
357 NEUROLEPTIC MALIGNANT SYNDROME 16
358 POST PROCEDURAL COMPLICATION 16
359 SINUS DISORDER 16
360 SPINAL OSTEOARTHRITIS 16
361 TEMPERATURE REGULATION DISORDER 16
362 VISUAL ACUITY REDUCED 16
363 ACCIDENTAL DEATH 15
364 ANAPHYLACTIC REACTION 15
365 BLOOD CALCIUM DECREASED 15
366 BLOOD TRIGLYCERIDES INCREASED 15
367 BURSITIS 15
368 CATARACT 15
369 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15
370 EAR INFECTION 15
371 EATING DISORDER 15
372 EPISTAXIS 15
373 EYE SWELLING 15
374 FOOD ALLERGY 15
375 FUNGAL INFECTION 15
376 GASTRITIS 15
377 HEART RATE IRREGULAR 15
378 HYPOTHERMIA 15
379 LOWER RESPIRATORY TRACT INFECTION 15
380 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 15
381 PRODUCT ADMINISTRATION INTERRUPTED 15
382 SCOLIOSIS 15
383 SEROTONIN SYNDROME 15
384 STAPHYLOCOCCAL INFECTION 15
385 THERAPY INTERRUPTED 15
386 UNDERDOSE 15
387 ABSCESS 14
388 ACCIDENTAL OVERDOSE 14
389 ACNE 14
390 APHONIA 14
391 ARTERIOSCLEROSIS CORONARY ARTERY 14
392 BACTERAEMIA 14
393 BODY TEMPERATURE INCREASED 14
394 COELIAC DISEASE 14
395 COLITIS ULCERATIVE 14
396 DEVICE ISSUE 14
397 DISEASE RECURRENCE 14
398 DRUG ADMINISTERED AT INAPPROPRIATE SITE 14
399 DYSTONIA 14
400 EYE DISORDER 14
401 FOETAL DEATH 14
402 HAEMATURIA 14
403 HEPATIC STEATOSIS 14
404 HIGH DENSITY LIPOPROTEIN DECREASED 14
405 LACRIMATION INCREASED 14
406 LIVER DISORDER 14
407 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14
408 MUSCLE TWITCHING 14
409 NASAL CONGESTION 14
410 NEURALGIA 14
411 NEUROTOXICITY 14
412 ORTHOSTATIC HYPOTENSION 14
413 SUICIDE ATTEMPT 14
414 AGGRESSION 13
415 APPLICATION SITE SWELLING 13
416 ARTERIOSCLEROSIS 13
417 BLOOD SODIUM DECREASED 13
418 BREAST CANCER 13
419 BRONCHIAL SECRETION RETENTION 13
420 CEREBRAL HAEMORRHAGE 13
421 DIASTOLIC DYSFUNCTION 13
422 ECONOMIC PROBLEM 13
423 EYE IRRITATION 13
424 FIBROMYALGIA 13
425 FREQUENT BOWEL MOVEMENTS 13
426 GASTROENTERITIS VIRAL 13
427 GENERALISED TONIC-CLONIC SEIZURE 13
428 HEAD DISCOMFORT 13
429 HEMIPARESIS 13
430 HERPES ZOSTER 13
431 HYPERNATRAEMIA 13
432 INTERNATIONAL NORMALISED RATIO INCREASED 13
433 LEUKOCYTOSIS 13
434 METASTASES TO BONE 13
435 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13
436 ORAL PAIN 13
437 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13
438 PARKINSON^S DISEASE 13
439 PRODUCT AVAILABILITY ISSUE 13
440 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13
441 SINUS TACHYCARDIA 13
442 SKIN DISORDER 13
443 SKIN ULCER 13
444 THERAPY NON-RESPONDER 13
445 THIRST 13
446 TREATMENT NONCOMPLIANCE 13
447 URINE OUTPUT DECREASED 13
448 WRONG PATIENT RECEIVED PRODUCT 13
449 ANGER 12
450 ANISOCORIA 12
451 APHAGIA 12
452 APNOEA 12
453 ARTHROPATHY 12
454 BLOOD CHOLESTEROL INCREASED 12
455 BLOOD GLUCOSE DECREASED 12
456 BLOOD PRESSURE FLUCTUATION 12
457 BONE DISORDER 12
458 BONE PAIN 12
459 BRAIN FOG 12
460 CLOSTRIDIUM DIFFICILE COLITIS 12
461 COAGULOPATHY 12
462 DEPRESSED MOOD 12
463 DEVICE LEAKAGE 12
464 DROOLING 12
465 DRUG TOXICITY 12
466 EAR PAIN 12
467 END STAGE RENAL DISEASE 12
468 EPICONDYLITIS 12
469 EPILEPSY 12
470 FAILURE TO SUSPEND MEDICATION 12
471 FEELING HOT 12
472 HAEMOPTYSIS 12
473 HYPOTHYROIDISM 12
474 INCOHERENT 12
475 JAUNDICE 12
476 LYMPHADENOPATHY 12
477 METASTASES TO LIVER 12
478 NEPHROGENIC ANAEMIA 12
479 PALLOR 12
480 PRODUCT SUBSTITUTION ISSUE 12
481 RASH MACULAR 12
482 RESPIRATORY ARREST 12
483 RHINORRHOEA 12
484 RIB FRACTURE 12
485 ROAD TRAFFIC ACCIDENT 12
486 SLEEP APNOEA SYNDROME 12
487 TASTE DISORDER 12
488 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12
489 URINE ODOUR ABNORMAL 12
490 AGEUSIA 11
491 APPLICATION SITE DRYNESS 11
492 BLOOD ALKALINE PHOSPHATASE INCREASED 11
493 CHRONIC GASTRITIS 11
494 COLD SWEAT 11
495 DEFORMITY 11
496 DRUG DOSE OMISSION 11
497 EYELID PTOSIS 11
498 FOOT FRACTURE 11
499 GALLBLADDER DISORDER 11
500 HEPATOTOXICITY 11
501 HYPERCHOLESTEROLAEMIA 11
502 HYPOACUSIS 11
503 HYPOCALCAEMIA 11
504 IMPAIRED QUALITY OF LIFE 11
505 LACTIC ACIDOSIS 11
506 LIMB INJURY 11
507 LUNG NEOPLASM MALIGNANT 11
508 MALNUTRITION 11
509 METABOLIC ACIDOSIS 11
510 MITRAL VALVE INCOMPETENCE 11
511 NIGHTMARE 11
512 OSTEONECROSIS OF JAW 11
513 POLYP 11
514 POOR QUALITY SLEEP 11
515 PROCEDURAL COMPLICATION 11
516 RECTAL HAEMORRHAGE 11
517 RESPIRATORY DISORDER 11
518 RESPIRATORY TRACT INFECTION 11
519 TRANSAMINASES INCREASED 11
520 VENTRICULAR EXTRASYSTOLES 11
521 ABNORMAL DREAMS 10
522 ABORTION SPONTANEOUS 10
523 APPLICATION SITE HYPERSENSITIVITY 10
524 APPLICATION SITE SCAB 10
525 APPLICATION SITE SCAR 10
526 BLOOD ALBUMIN DECREASED 10
527 BLOOD PRESSURE ABNORMAL 10
528 CHOLESTASIS 10
529 CRANIOCEREBRAL INJURY 10
530 DRUG EFFECT DECREASED 10
531 DRUG PRESCRIBING ERROR 10
532 GENERALISED OEDEMA 10
533 HAEMATOCRIT DECREASED 10
534 HAEMODYNAMIC INSTABILITY 10
535 HEPATIC FUNCTION ABNORMAL 10
536 HYPERCALCAEMIA 10
537 HYPERTENSIVE CRISIS 10
538 HYPOMAGNESAEMIA 10
539 INCORRECT PRODUCT ADMINISTRATION DURATION 10
540 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 10
541 LIGAMENT RUPTURE 10
542 MEAN CELL VOLUME DECREASED 10
543 OSTEONECROSIS 10
544 OSTEOPOROSIS 10
545 PATHOLOGICAL FRACTURE 10
546 PHOTOSENSITIVITY REACTION 10
547 POLLAKIURIA 10
548 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 10
549 PRODUCT STORAGE ERROR 10
550 SKIN BURNING SENSATION 10
551 SKIN REACTION 10
552 SNORING 10
553 SPLENOMEGALY 10
554 TENOSYNOVITIS 10
555 THERAPEUTIC PRODUCT EFFECT DECREASED 10
556 TRANSIENT ISCHAEMIC ATTACK 10
557 TRIGGER FINGER 10
558 TUBULOINTERSTITIAL NEPHRITIS 10
559 VOLVULUS 10
560 ACUTE RESPIRATORY DISTRESS SYNDROME 9
561 ANAPHYLACTIC SHOCK 9
562 ANGINA PECTORIS 9
563 APPLICATION SITE DISCHARGE 9
564 APPLICATION SITE URTICARIA 9
565 BLINDNESS UNILATERAL 9
566 BLOOD LACTATE DEHYDROGENASE INCREASED 9
567 CHOLECYSTECTOMY 9
568 CHOLECYSTITIS 9
569 CHROMATURIA 9
570 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9
571 COMPLETED SUICIDE 9
572 CORONARY ARTERY DISEASE 9
573 DECUBITUS ULCER 9
574 DYSPNOEA EXERTIONAL 9
575 EXPIRED PRODUCT ADMINISTERED 9
576 EXTRA DOSE ADMINISTERED 9
577 EYE INFECTION 9
578 FAECALOMA 9
579 FUNGAL OESOPHAGITIS 9
580 GASTROINTESTINAL STROMAL TUMOUR 9
581 GLAUCOMA 9
582 HAEMATEMESIS 9
583 HEPATIC CIRRHOSIS 9
584 HEPATIC FAILURE 9
585 HERNIA 9
586 HYPERHOMOCYSTEINAEMIA 9
587 HYPOGLYCAEMIA 9
588 HYSTERECTOMY 9
589 INTERSTITIAL LUNG DISEASE 9
590 INTERVERTEBRAL DISC DEGENERATION 9
591 KIDNEY INFECTION 9
592 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9
593 LIVER FUNCTION TEST ABNORMAL 9
594 LOCALISED INFECTION 9
595 LOWER RESPIRATORY TRACT CONGESTION 9
596 LUNG INFECTION 9
597 MIDDLE INSOMNIA 9
598 MIOSIS 9
599 MUSCLE RIGIDITY 9
600 NODULE 9
601 PARALYSIS 9
602 PARKINSONISM 9
603 PRODUCT DOSE OMISSION IN ERROR 9
604 PRODUCT LABEL CONFUSION 9
605 PRODUCT PRESCRIBING ERROR 9
606 PRODUCT SUPPLY ISSUE 9
607 PULSELESS ELECTRICAL ACTIVITY 9
608 RASH PRURITIC 9
609 REBOUND EFFECT 9
610 RENAL ARTERY STENOSIS 9
611 RENAL CYST 9
612 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9
613 RHABDOMYOLYSIS 9
614 SCIATICA 9
615 SNEEZING 9
616 SUPRAVENTRICULAR EXTRASYSTOLES 9
617 TARDIVE DYSKINESIA 9
618 TORTICOLLIS 9
619 VENTRICULAR TACHYCARDIA 9
620 WHITE BLOOD CELLS URINE POSITIVE 9
621 ABDOMINAL PAIN LOWER 8
622 ACUTE MYELOID LEUKAEMIA 8
623 AGRANULOCYTOSIS 8
624 ANTIPSYCHOTIC DRUG LEVEL INCREASED 8
625 BLINDNESS TRANSIENT 8
626 BLOOD MAGNESIUM DECREASED 8
627 BRAIN OEDEMA 8
628 BRUXISM 8
629 CARDIOMEGALY 8
630 DIVERTICULITIS 8
631 EMOTIONAL DISORDER 8
632 EYE PRURITUS 8
633 FACE OEDEMA 8
634 FAECAL VOMITING 8
635 FAECES DISCOLOURED 8
636 FAILURE TO THRIVE 8
637 GLOMERULAR FILTRATION RATE DECREASED 8
638 HYPOPHOSPHATAEMIA 8
639 INCISION SITE PAIN 8
640 INFUSION SITE PAIN 8
641 INTENTIONAL DOSE OMISSION 8
642 INTRAOCULAR PRESSURE INCREASED 8
643 KLEBSIELLA INFECTION 8
644 LEFT VENTRICULAR DYSFUNCTION 8
645 LIVER FUNCTION TEST INCREASED 8
646 LIVER INJURY 8
647 MUSCULOSKELETAL PAIN 8
648 NIGHT SWEATS 8
649 OCULAR DISCOMFORT 8
650 PERSECUTORY DELUSION 8
651 PHARYNGEAL OEDEMA 8
652 PREMATURE DELIVERY 8
653 PRODUCT USE COMPLAINT 8
654 PUPIL FIXED 8
655 PUPILS UNEQUAL 8
656 RED CELL DISTRIBUTION WIDTH INCREASED 8
657 RETINAL DETACHMENT 8
658 SINUS BRADYCARDIA 8
659 SKIN FISSURES 8
660 THERAPY CESSATION 8
661 THINKING ABNORMAL 8
662 THROAT TIGHTNESS 8
663 TOOTH LOSS 8
664 TOXIC EPIDERMAL NECROLYSIS 8
665 TUMOUR LYSIS SYNDROME 8
666 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7
667 ANGLE CLOSURE GLAUCOMA 7
668 ANOREXIA 7
669 APPLICATION SITE EXFOLIATION 7
670 APPLICATION SITE HAEMORRHAGE 7
671 APPLICATION SITE INFLAMMATION 7
672 BACK DISORDER 7
673 BLEPHAROSPASM 7
674 BLOOD CREATINE PHOSPHOKINASE INCREASED 7
675 BLOOD CREATININE DECREASED 7
676 BLOOD PHOSPHORUS DECREASED 7
677 BONE MARROW FAILURE 7
678 CACHEXIA 7
679 CARDIOVASCULAR DISORDER 7
680 CENTRAL NERVOUS SYSTEM LESION 7
681 CENTRAL VENOUS CATHETERISATION 7
682 CONCOMITANT DISEASE AGGRAVATED 7
683 CONCUSSION 7
684 DECREASED ACTIVITY 7
685 DECREASED IMMUNE RESPONSIVENESS 7
686 DEVICE DISLOCATION 7
687 DRUG ABUSE 7
688 DRUG EFFECT LESS THAN EXPECTED 7
689 DRUG LEVEL INCREASED 7
690 ELECTROLYTE IMBALANCE 7
691 ENDOMETRIOSIS 7
692 ENTEROCOLITIS 7
693 FEELING COLD 7
694 FEMUR FRACTURE 7
695 FLANK PAIN 7
696 FLUID INTAKE REDUCED 7
697 FULL BLOOD COUNT DECREASED 7
698 GASTRIC DISORDER 7
699 GASTROENTERITIS 7
700 HAEMATOMA 7
701 HEPATITIS 7
702 HIP FRACTURE 7
703 HOSPICE CARE 7
704 HYPERPROLACTINAEMIA 7
705 HYPERREFLEXIA 7
706 HYPOALBUMINAEMIA 7
707 IDEAS OF REFERENCE 7
708 INCORRECT DOSAGE ADMINISTERED 7
709 INFUSION SITE SWELLING 7
710 INTRA-ABDOMINAL HAEMATOMA 7
711 JOINT INJURY 7
712 JOINT RANGE OF MOTION DECREASED 7
713 LIGAMENT SPRAIN 7
714 LOWER GASTROINTESTINAL HAEMORRHAGE 7
715 LUNG INFILTRATION 7
716 MAJOR DEPRESSION 7
717 MALIGNANT MELANOMA 7
718 MELAENA 7
719 METABOLIC DISORDER 7
720 METASTASES TO LUNG 7
721 MOOD SWINGS 7
722 MOTOR DYSFUNCTION 7
723 MYELODYSPLASTIC SYNDROME 7
724 NO THERAPEUTIC RESPONSE 7
725 NONSPECIFIC REACTION 7
726 OBESITY 7
727 ORAL CANDIDIASIS 7
728 ORAL HERPES 7
729 OROPHARYNGEAL DISCOMFORT 7
730 PAIN OF SKIN 7
731 PHARYNGITIS STREPTOCOCCAL 7
732 POST-TRAUMATIC STRESS DISORDER 7
733 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7
734 PREMATURE LABOUR 7
735 PSYCHOMOTOR HYPERACTIVITY 7
736 PULMONARY HYPERTENSION 7
737 PULMONARY MASS 7
738 RESPIRATORY ACIDOSIS 7
739 RESPIRATORY TRACT CONGESTION 7
740 RESTLESS LEGS SYNDROME 7
741 SECRETION DISCHARGE 7
742 SENSORY DISTURBANCE 7
743 SERUM FERRITIN INCREASED 7
744 STAPHYLOCOCCAL SEPSIS 7
745 TENDERNESS 7
746 THERAPEUTIC RESPONSE DECREASED 7
747 TRACHEOBRONCHITIS 7
748 TROPONIN INCREASED 7
749 TYPE 2 DIABETES MELLITUS 7
750 VAGINAL HAEMORRHAGE 7
751 WEIGHT FLUCTUATION 7
752 ABDOMINAL TENDERNESS 6
753 ACCIDENTAL EXPOSURE 6
754 ADVERSE REACTION 6
755 APLASTIC ANAEMIA 6
756 APPLICATION SITE EROSION 6
757 ASTIGMATISM 6
758 BLOOD LACTIC ACID INCREASED 6
759 BLOOD POTASSIUM INCREASED 6
760 BLOOD URINE PRESENT 6
761 BONE DENSITY DECREASED 6
762 CANDIDA INFECTION 6
763 CARDIAC FAILURE ACUTE 6
764 CARDIOGENIC SHOCK 6
765 CATHETERISATION CARDIAC 6
766 CLONUS 6
767 CLOSTRIDIUM DIFFICILE INFECTION 6
768 COLITIS ISCHAEMIC 6
769 COMPLICATION ASSOCIATED WITH DEVICE 6
770 CYANOSIS 6
771 DECREASED INTEREST 6
772 DEVICE OCCLUSION 6
773 DYSMENORRHOEA 6
774 DYSPHEMIA 6
775 EMERGENCY CARE 6
776 EMPHYSEMA 6
777 EXTRAPYRAMIDAL DISORDER 6
778 EYE MOVEMENT DISORDER 6
779 FACIAL PARALYSIS 6
780 FEELING JITTERY 6
781 FISTULA 6
782 FOETAL EXPOSURE DURING PREGNANCY 6
783 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6
784 GASTRIC ULCER 6
785 GASTROINTESTINAL MOTILITY DISORDER 6
786 GROIN PAIN 6
787 HAEMOGLOBIN INCREASED 6
788 HAEMORRHAGE INTRACRANIAL 6
789 HAIR COLOUR CHANGES 6
790 HALLUCINATIONS, MIXED 6
791 HEPATIC LESION 6
792 HEPATITIS CHOLESTATIC 6
793 HEPATOCELLULAR INJURY 6
794 HEPATOMEGALY 6
795 HERPES SIMPLEX 6
796 HYPERAEMIA 6
797 HYPERVOLAEMIA 6
798 HYPOVENTILATION 6
799 HYPOVOLAEMIA 6
800 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6
801 IMMUNE SYSTEM DISORDER 6
802 INCREASED APPETITE 6
803 INITIAL INSOMNIA 6
804 INJECTION SITE REACTION 6
805 INJURY ASSOCIATED WITH DEVICE 6
806 INTENTIONAL OVERDOSE 6
807 INTESTINAL PERFORATION 6
808 ISCHAEMIC STROKE 6
809 LABORATORY TEST ABNORMAL 6
810 MACULAR HOLE 6
811 MANIA 6
812 MASS 6
813 METASTASES TO SPINE 6
814 MICROCYTIC ANAEMIA 6
815 MOUTH ULCERATION 6
816 MULTIPLE MYELOMA 6
817 MULTIPLE SCLEROSIS 6
818 MUSCLE ATROPHY 6
819 MUSCLE TIGHTNESS 6
820 NASAL DRYNESS 6
821 NERVE INJURY 6
822 ORAL DISCOMFORT 6
823 OSTEOMYELITIS 6
824 OSTEOPENIA 6
825 OSTEOSCLEROSIS 6
826 PELVIC FRACTURE 6
827 PERIPHERAL COLDNESS 6
828 PERONEAL NERVE PALSY 6
829 PLATELET COUNT INCREASED 6
830 PORTAL HYPERTENSION 6
831 POST PROCEDURAL INFECTION 6
832 PRESYNCOPE 6
833 PROCEDURAL PAIN 6
834 PRODUCT DOSE OMISSION 6
835 PROSTATE CANCER 6
836 PROTEINURIA 6
837 PRURITUS GENERALISED 6
838 PYELONEPHRITIS 6
839 RADIOTHERAPY 6
840 RALES 6
841 RASH PAPULAR 6
842 RED BLOOD CELL ELLIPTOCYTES PRESENT 6
843 RENAL TUBULAR NECROSIS 6
844 RHINOVIRUS INFECTION 6
845 SHOCK 6
846 SKIN CANCER 6
847 SKIN EROSION 6
848 SKIN INFECTION 6
849 SPINAL COMPRESSION FRACTURE 6
850 STATUS EPILEPTICUS 6
851 SUDDEN DEATH 6
852 THERMAL BURN 6
853 TONGUE BITING 6
854 TOOTHACHE 6
855 TRANSFUSION 6
856 TRISMUS 6
857 UPPER GASTROINTESTINAL HAEMORRHAGE 6
858 VENOOCCLUSIVE LIVER DISEASE 6
859 WOUND INFECTION 6
860 ABDOMINAL HERNIA 5
861 ABDOMINAL INFECTION 5
862 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5
863 ADENOVIRUS INFECTION 5
864 ANAL INCONTINENCE 5
865 ANURIA 5
866 APPLICATION SITE DISCOLOURATION 5
867 APPLICATION SITE PAPULES 5
868 ARTERIAL OCCLUSIVE DISEASE 5
869 ATRIOVENTRICULAR BLOCK COMPLETE 5
870 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5
871 BACTERIAL INFECTION 5
872 BILIRUBIN CONJUGATED INCREASED 5
873 BLADDER DISORDER 5
874 BLOOD SODIUM INCREASED 5
875 BLOOD TEST ABNORMAL 5
876 BODY HEIGHT DECREASED 5
877 BONE LESION 5
878 BREATH SOUNDS ABNORMAL 5
879 BUNDLE BRANCH BLOCK LEFT 5
880 CARDIAC OPERATION 5
881 CHOLECYSTITIS CHRONIC 5
882 COLON CANCER 5
883 CORONARY ARTERY BYPASS 5
884 DEAFNESS 5
885 DEAFNESS PERMANENT 5
886 DENTAL CARIES 5
887 DERMATITIS ATOPIC 5
888 DEVICE MALFUNCTION 5
889 DEVICE USE ERROR 5
890 DRUG EFFECT INCOMPLETE 5
891 EAR DISORDER 5
892 EMERGENCY CARE EXAMINATION 5
893 EOSINOPHILIA 5
894 ERUCTATION 5
895 ESCHERICHIA BACTERAEMIA 5
896 ESCHERICHIA INFECTION 5
897 EXOSTOSIS 5
898 FACIAL PAIN 5
899 FEELING DRUNK 5
900 FEELING OF DESPAIR 5
901 FORMICATION 5
902 GASTRIC CANCER 5
903 GASTROINTESTINAL INFECTION 5
904 GASTROINTESTINAL PAIN 5
905 GAZE PALSY 5
906 HAEMOPHILUS SEPSIS 5
907 HANGOVER 5
908 HYDRONEPHROSIS 5
909 HYPERACUSIS 5
910 HYPERBILIRUBINAEMIA 5
911 HYPERPARATHYROIDISM SECONDARY 5
912 HYPOPNOEA 5
913 IDIOPATHIC THROMBOCYTOPENIC PURPURA 5
914 IMPAIRED HEALING 5
915 INCONTINENCE 5
916 INCORRECT DRUG ADMINISTRATION RATE 5
917 INJECTION SITE BRUISING 5
918 INJECTION SITE ERYTHEMA 5
919 INJECTION SITE MASS 5
920 INSURANCE ISSUE 5
921 INTENTIONAL SELF-INJURY 5
922 INTERCEPTED MEDICATION ERROR 5
923 INTESTINAL PSEUDO-OBSTRUCTION 5
924 IRON DEFICIENCY ANAEMIA 5
925 IRRITABLE BOWEL SYNDROME 5
926 LARGE INTESTINE POLYP 5
927 LUNG NEOPLASM 5
928 MENORRHAGIA 5
929 MOOD ALTERED 5
930 MULTIPLE ALLERGIES 5
931 MUSCLE STRAIN 5
932 MUSCULOSKELETAL DISCOMFORT 5
933 MYOCARDIAL ISCHAEMIA 5
934 NEUTROPENIC COLITIS 5
935 NEUTROPENIC SEPSIS 5
936 OBSTRUCTION 5
937 OCCUPATIONAL EXPOSURE TO PRODUCT 5
938 OLIGURIA 5
939 ORAL DISORDER 5
940 ORAL MUCOSAL BLISTERING 5
941 OVARIAN CANCER RECURRENT 5
942 PANCREATITIS ACUTE 5
943 PARAESTHESIA ORAL 5
944 PERFORMANCE STATUS DECREASED 5
945 PERITONITIS 5
946 PHARYNGITIS 5
947 PHYSICAL DISABILITY 5
948 PNEUMONIA FUNGAL 5
949 PORPHYRIA ACUTE 5
950 POST PROCEDURAL HAEMORRHAGE 5
951 PRESCRIBED UNDERDOSE 5
952 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5
953 PRODUCT ADMINISTRATION ERROR 5
954 PRODUCT DISTRIBUTION ISSUE 5
955 PRODUCT LABEL ISSUE 5
956 PRODUCT PACKAGING CONFUSION 5
957 PRODUCT PHYSICAL ISSUE 5
958 PRODUCT PRESCRIBING ISSUE 5
959 PROTHROMBIN TIME PROLONGED 5
960 REFUSAL OF TREATMENT BY PATIENT 5
961 RIGHT VENTRICULAR FAILURE 5
962 SCHIZOPHRENIA 5
963 SKIN LACERATION 5
964 SKIN PLAQUE 5
965 SPINAL PAIN 5
966 SPUTUM DISCOLOURED 5
967 STAPHYLOCOCCUS TEST POSITIVE 5
968 SUBDURAL HAEMATOMA 5
969 TEMPERATURE INTOLERANCE 5
970 THERAPEUTIC RESPONSE CHANGED 5
971 TONGUE INJURY 5
972 VASCULAR DEVICE INFECTION 5
973 VITREOUS FLOATERS 5
974 VOCAL CORD PARALYSIS 5
975 WALKING AID USER 5
976 WOUND 5
977 WOUND SECRETION 5
978 WRONG PRODUCT ADMINISTERED 5
979 ACCOMMODATION DISORDER 4
980 ACIDOSIS 4
981 ACUTE ABDOMEN 4
982 ACUTE LYMPHOCYTIC LEUKAEMIA 4
983 ACUTE MYOCARDIAL INFARCTION 4
984 ADRENAL INSUFFICIENCY 4
985 ANKLE FRACTURE 4
986 ANOSMIA 4
987 ANTICHOLINERGIC EFFECT 4
988 ANXIETY DISORDER 4
989 APPLICATION SITE DERMATITIS 4
990 APPLICATION SITE ULCER 4
991 APTYALISM 4
992 ASPERGILLUS INFECTION 4
993 ATAXIA 4
994 ATRIAL TACHYCARDIA 4
995 BASAL CELL CARCINOMA 4
996 BLEPHARITIS 4
997 BLOOD ALKALINE PHOSPHATASE DECREASED 4
998 BLOOD IMMUNOGLOBULIN G DECREASED 4
999 BLOOD PRESSURE DIASTOLIC INCREASED 4